11/7/26 From Awareness to Activation - Converting Rare Patient Identification into Trial Enrollment Previous From Data to Discovery: Finding the Right Patients Across the Therapy Lifecycle Next Mapping the Rare Patient Journey You Might Also Like Learning More from Less: Smarter Design and Execution in Rare Disease Trials Inside the FDA Mindset - Negotiating Endpoints and Surrogates Patient Organizations as Evidence Partners: Shaping the Science Behind Rare Disease Approval Write Your Own Endpoint Justification Bridging the Generational Divide in Rare Disease Clinical Trials: Tailoring Communication to Maximize Recruitment, Retention, and Equity
11/7/26 From Awareness to Activation - Converting Rare Patient Identification into Trial Enrollment Previous From Data to Discovery: Finding the Right Patients Across the Therapy Lifecycle Next Mapping the Rare Patient Journey You Might Also Like Learning More from Less: Smarter Design and Execution in Rare Disease Trials Inside the FDA Mindset - Negotiating Endpoints and Surrogates Patient Organizations as Evidence Partners: Shaping the Science Behind Rare Disease Approval Write Your Own Endpoint Justification Bridging the Generational Divide in Rare Disease Clinical Trials: Tailoring Communication to Maximize Recruitment, Retention, and Equity
